📈 Jumpstart Signal Watchlist — October 12, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $15.17 is 1% below 3yr high $15.37 · ⏳ SMA200 $7.61 (current price $15.17 is above) · 💰 Market Cap $856M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (9.4%)
- 🔔 Strong above EMA50 (19.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×1 ⚪️×1).
✅ DA Davidson raises Paysign stock price target to $15 on growth outlook — Investing.com.
🤖 DA Davidson raised its price target from $12 to $15 while maintaining a Buy rating. The article also notes Paysign’s second-quarter results beat analyst expectations and that the company raised its full-year outlook.
⚪️ Paysign EVP, operations Joan Herman sells $716,899 in shares — Investing.com.
🤖 The article reports that an executive sold shares under a previously adopted Rule 10b5-1 trading plan. This is a disclosed insider transaction, not by itself a clear directional catalyst for the stock.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: OneSpan provides cybersecurity and digital agreement solutions, including identity verification, authentication, fraud prevention, and mobile app security. Its digital agreement products support secure e-signatures, online notarization, and automated document workflows.
- 🎯 Current $17.85 is 12% below 3yr high $20.23 · ⏳ SMA200 $13.59 (current price $17.85 is above) · 💰 Market Cap $657M
- OSPN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 39/60
- 🏦 Low drawdown (14.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; ROE 25% (>15%); Low LT D/E 0.00 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×1).
✅ OneSpan Expands OneSpan Sign Beyond eSignature Capabilities to Move Customer-Facing Agreements Forward, Faster and With Greater Confidence — Business Wire.
🤖 OneSpan announced new and planned capabilities that extend its digital agreements portfolio beyond e-signatures, including AI-assisted document preparation, identity verification, and workflow integrations. The expansion could strengthen the product offering and support growth, though the announcement does not provide financial results or guidance.
🍭 Bonus (B): 10/10 — Computer Integrated Systems Design (Technology sector)

🏢 What they do: Red Violet, Inc. provides identity intelligence software and data solutions for identity verification, fraud detection and prevention, risk mitigation, investigations, due diligence, customer acquisition, and asset recovery. Its products include idiCORE and FOREWARN.
- 🎯 Current $80.17 is 0% below 3yr high $80.25 · ⏳ SMA200 $55.47 (current price $80.17 is above) · 💰 Market Cap $1.1B
- RDVT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (13.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 89% (>20%); Revenue growth 23% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Red Violet (NASDAQ:RDVT) Stock Rating Upgraded by Wall Street Zen — MarketBeat.
🤖 Wall Street Zen upgraded Red Violet from Hold to Buy, adding to the positive analyst outlook for the stock. The article also notes a consensus Buy rating and an $83.50 average price target.
✅ Red Violet (RDVT) Expands FOREWARN Reach Through This Latest Partnership — Yahoo Finance.
🤖 FOREWARN partnered with the Pacific West Association of REALTORS to make its identity-verification and safety tools available to more than 10,000 members. The partnership expands the potential reach of Red Violet’s services.
✅ Red Violet (NASDAQ:RDVT) Upgraded at Zacks Research — MarketBeat.
🤖 Zacks Research upgraded Red Violet from Hold to Strong Buy, a favorable analyst-rating change. The article also reports a consensus Buy rating and an $83.50 average price target.
🍭 Bonus (B): 10/10 — Prepackaged Software (Technology sector)

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $59.82 is 0% below 3yr high $59.86 · ⏳ SMA200 $49.43 (current price $59.82 is above) · 💰 Market Cap $14.9B
- EXEL shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (11.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 26% (>20%); ROE 47% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 2/20
- 📈 RSI at 62 showing strength
📢 Sentiment (S): 4/10
- 🗞️ News sentiment is negative (mixed coverage; ✅×2 ❌×3; showing 4 of 5).
✅ Exelixis (EXEL) is a Top-Ranked Growth Stock: Should You Buy? — Zacks.
🤖 The article highlights upward revisions to the 2026 consensus EPS estimate, projected earnings growth, and Exelixis’s history of earnings surprises. These factors support a favorable growth outlook, although Zacks assigns the stock a Hold rank.
✅ Exelixis (NASDAQ:EXEL) Price Target Raised to $54.00 — MarketBeat.
🤖 Truist raised its price target from $52 to $54 while keeping a Hold rating. The higher target is a modestly positive analyst revision, though the firm still sees limited upside.
❌ Exelixis FY2027 Earnings Forecast Lowered by Zacks Research — MarketBeat.
🤖 Zacks Research lowered its FY2027 EPS estimate slightly, from $3.59 to $3.56, while maintaining a Hold rating. The modest downward revision is a mildly negative signal for expectations.
❌ Exelixis (EXEL) Faces a Three-Month Zanzalintinib Review ... — Yahoo Finance.
🤖 The FDA extended its review of zanzalintinib by three months after requesting updated safety and efficacy information, moving the target action date to March 3, 2027. The delay postpones a potential regulatory decision and launch.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $25.08 is 5% below 3yr high $26.52 · ⏳ SMA200 $17.19 (current price $25.08 is above) · 💰 Market Cap $3.6B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 55 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Magnite Successfully Completes Term Loan and Revolving Credit Facility Repricing — Yahoo Finance.
🤖 Magnite reduced interest margins on its term loan and revolving credit facility. The repricing is expected to save approximately $1.8 million in annualized cash interest, modestly improving cash flow.
✅ Magnite (MGNI) Lands HP TV+ Deal But Is The Upside Already Priced In — Yahoo Finance.
🤖 Magnite secured a role as the primary video ad server and programmatic technology provider for HP TV+. The partnership offers a new distribution opportunity, though the article also raises the question of whether the potential upside is already reflected in the share price.
✅ Magnite Advances Agentic Vision as Major Media Owners, Buyers and Technology Players Leverage Orchestration Layer — GlobeNewswire.
🤖 Magnite announced expanded omnichannel capabilities and third-party integrations for Magnite Orchestration, its coordination layer for AI-driven advertising systems. The expansion could strengthen its offering across streaming, linear TV, audio, and display.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $70.33 is 4% below 3yr high $73.46 · ⏳ SMA200 $38.08 (current price $70.33 is above) · 💰 Market Cap $93.4B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.09 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.7%)
- 🔔 Strong above EMA50 (18.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ HPE Partners With NVDA: Can it Help Challenge SMCI & DELL? — Yahoo Finance.
🤖 HPE partnered with NVIDIA to offer integrated AI infrastructure for enterprise and high-performance computing workloads. The collaboration could strengthen HPE’s position in the growing AI infrastructure market.
✅ Bull of the Day: Hewlett Packard Enterprise (HPE) — Zacks.
🤖 The article highlights HPE’s strong fiscal third-quarter results, raised fiscal 2026 and 2027 outlooks, and rising earnings estimates. These results and forecasts point to improving growth expectations.
✅ HPE Stock Has Nearly Tripled. Here's Why Wall Street ... — Yahoo Finance.
🤖 The article cites strong cloud and AI revenue, higher server margins, and raised fiscal-year forecasts, alongside analyst price-target increases. These factors support a positive outlook, though the stock’s substantial rally is also noted.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Nutanix provides software for running and managing applications and data across private data centers, edge locations, and public clouds. Its platform combines software-defined computing, storage, virtualization, and cloud-management tools to support hybrid and multicloud environments.
- 🎯 Current $74.14 is 11% below 3yr high $83.07 · ⏳ SMA200 $51.31 (current price $74.14 is above) · 💰 Market Cap $16.8B
- NTNX passed all filters and shows favorable conditions.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 3007% (>20%); Revenue growth 16% (>15%); ROE 214% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (10.5%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral (mixed coverage; ✅×1 ❌×1 ⚪️×1).
✅ Needham raises Nutanix stock price target to $90 on hybrid cloud — Investing.com.
🤖 Needham initiated coverage with a Buy rating and a $90 price target, citing Nutanix’s hybrid-cloud prospects. The favorable analyst view is a positive signal for the stock.
❌ Nutanix CEO Rajiv Ramaswami sells $29.46m in stock — Investing.com.
🤖 CEO Rajiv Ramaswami sold 400,000 shares in transactions on October 6 and 7. The sale may weigh on sentiment, though the article reports the transactions rather than a change in the company’s outlook.
⚪️ Nutanix (NTNX) Reshapes Sales Leadership As Tarkan Maner Exits — Yahoo Finance.
🤖 President and Chief Commercial Officer Tarkan Maner is leaving, and CEO Rajiv Ramaswami will take direct oversight of global go-to-market and customer experience teams. The article reports a leadership change but does not establish whether it will improve or weaken business performance.
🍭 Bonus (B): 10/10 — Prepackaged Software (Technology sector)